Qube Research & Technologies LTD Centogene N.V. Call Options Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CNTG
# of Institutions
16Shares Held
2.14MCall Options Held
0Put Options Held
0-
Platinum Investment Management LTD Sydney Australia 2000, C31.19MShares$486,3010.03% of portfolio
-
Scoggin Management LP New York, NY532KShares$217,9440.15% of portfolio
-
Wells Fargo & Company San Francisco, CA197KShares$80,8310.0% of portfolio
-
Landscape Capital Management, L.L.C.120KShares$49,1590.01% of portfolio
-
Stifel Financial Corp St. Louis, MO22.5KShares$9,2040.0% of portfolio
About Centogene N.V.
- Ticker CNTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,081,600
- Market Cap $11.1M
- Description
- Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...